CYCCyclopharm
About Cyclopharm
Cyclopharm (ASX:CYC) is a nuclear medicine company that develops, manufactures, and markets radiopharmaceuticals for the diagnosis and treatment of disease. The company’s flagship product is Technegas, which is a radiopharmaceutical used for functional lung ventilation imaging.
What is CYC known for?
Snapshot
Public AU
Ownership
1986
Year founded
10
Employees
New South Wales, Australia
Head office
Loading Map...
Operations
All Locations
Australia
Products and/or services of Cyclopharm
- Technegas: A radiopharmaceutical used for functional lung ventilation imaging.
- Research and development: Cyclopharm is actively engaged in research and development, with a focus on developing new radiopharmaceuticals for the diagnosis and treatment of pulmonary diseases.
Cyclopharm executive team
- Mr. James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDMCEO, MD, Company Secretary & Director
- Mr. Jason SmithChief Financial Officer
- Mr. Mathew FaragChief Operating Officer
- Ms. Sally-Ann CorneliusHead of Sales
- Ms. Niamh McAreeHead of Quality and Regulatory
- Mr. Chris QuinnHead of Service
- Ms. Sui Ling CheahFinancial Controller
- Mr. Lynn McLauchlinGeneral Manager of Canada
- Mr. Gary T. SomervilleQuality & Regulatory Manager